欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号
DE/H/3658/003
药品名称
Ceftriaxon Eberth 2 g Pulver zur Herstellung einer Infusionslösung
活性成分
ceftriaxone disodium 2.39 mg
剂型
Powder for solution for infusion
上市许可持有人
Dr. Friedrich Eberth Arzneimittel GmbH Am Bahnhof 2 92289 Ursensollen Germany
参考成员国 - 产品名称
Germany (DE)
Ceftriaxon Pharma Resources 2,0 g Pulver zur Herstellung einer Infusionslösung
互认成员国 - 产品名称
Austria (AT)
许可日期
2013/09/04
最近更新日期
2023/10/24
药物ATC编码
J01DD04 ceftriaxone
申请类型
TypeLevel1：
Abridged
TypeLevel2：
Additional Strength/Form
TypeLevel3：
Other Generic application Art 10.3 Dir 2001/83/EC
TypeLevel4：
Chemical Substance
TypeLevel5：
Prescription Only
附件文件下载
Final SPC
|
common_final_spc_DE3658_003__V026
Date of last change:2023/10/11
Final Product Information
|
final-commonPL-3658-016
Date of last change:2021/11/04
Final Product Information
|
final-common-SPC-3658-016
Date of last change:2021/11/04
Final PL
|
DE_3658_002_pal-common_Ceftri_E_1g_Plv_v7-4_2020-05-27_clean_20200529_renewal
Date of last change:2020/05/29
Final Labelling
|
DE_3658_002_labip-common_Ceftri_E_1g_Plv_v7-1_2020-04-15_clean_20200529_renewal
Date of last change:2020/05/29
Final PL
|
DE_3658_003_pal-common_Ceftri_E_2g_Plv_v8-4_2020-05-27_clean_20200529_renewal
Date of last change:2020/05/29
Final PL
|
DE_3658_004_pal-common_Ceftri_E_2g_Plv+LM_v8-4_2020-05-27_clean_20200529_renewal
Date of last change:2020/05/29
Final Labelling
|
DE_3658_003_labop-common_Ceftri_E_2g_Plv_v6-1_2020-04-29_clean_20200529_renewal
Date of last change:2020/05/29
Final Labelling
|
DE_3658_002_labop-common_Ceftri_E_1g_Plv_v6-1_2020-04-29_clean_20200529_renewal
Date of last change:2020/05/29
Final Labelling
|
DE_3658_003_labip-common_Ceftri_E_2g_Plv_v7-1_2020-04-15_clean_20200529_renewal
Date of last change:2020/05/29
Final Labelling
|
DE_3658_004_labip-common_Plv_Ceftri_E_2g_Plv+LM_v7-1_2020-04-30_clean_20200529_renewal
Date of last change:2020/05/29
Final Labelling
|
DE_3658_004_labop-common_Ceftri_E_2g_Plv+LM_v6-1_2020-04-29_clean._20200529_renewal
Date of last change:2020/05/29
PAR
|
PAREN-DE3658_Ceftriaxon-20140204
Date of last change:2014/02/04
市场状态
Positive
©2006-2024
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase